Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
Sponsor: St. Jude Children's Research Hospital
Summary
Human gene therapy products are designed to achieve therapeutic effect through genetic modifications of human cells using retroviral or lentiviral vectors, resulting in permanent or long-acting changes in the human body. With this genetic modification comes risk of undesirable adverse events. Due to this risk, the Food and Drug Administration (FDA) and the Center for Biologics Evaluation and research (CBER) require long-term follow-up (15 years) of participants that receive investigational gene therapy products that meet defined criteria. This protocol will provide a mechanism by which to appropriately monitor participants that have received a genetically modified cellular product on a St. Jude initiated study.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2023-02-08
Completion Date
2052-12-01
Last Updated
2025-07-01
Healthy Volunteers
No
Locations (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, United States